{"result": {"id": "b83fe213-ae26-41d7-99fb-31b403c94d19", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>PERINDOPRIL<|>ORGANIZATION<|>Perindopril is an antihypertensive drug studied in the PROGRESS trial for reducing vascular cognitive impairment in hypertensive patients>  \n##  \n(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a medical condition and major risk factor for coronary artery disease and cognitive impairment>)  \n##  \n(\"entity\"<|>CORONARY ARTERY DISEASE<|>EVENT<|>Coronary artery disease is a cardiovascular condition strongly associated with hypertension>)  \n##  \n(\"entity\"<|>MYOCARDIAL INFARCTION<|>EVENT<|>Myocardial infarction (heart attack) is a severe coronary event where hypertension is a major risk factor>)  \n##  \n(\"entity\"<|>STROKE<|>EVENT<|>Stroke is a cerebrovascular event whose risk can be reduced by antihypertensive treatment>)  \n##  \n(\"entity\"<|>HEART FAILURE<|>EVENT<|>Heart failure is a condition whose risk can be lowered through blood pressure management>)  \n##  \n(\"relationship\"<|>HYPERTENSION<|>CORONARY ARTERY DISEASE<|>Hypertension is a major independent risk factor for coronary artery disease<|>8>)  \n##  \n(\"relationship\"<|>HYPERTENSION<|>MYOCARDIAL INFARCTION<|>Hypertension accounts for 25%-30% of population-attributable risk for acute myocardial infarction<|>7>)  \n##  \n(\"relationship\"<|>HYPERTENSION<|>STROKE<|>Blood pressure reduction lowers stroke risk by 26% in patients with coronary artery disease<|>7>)  \n##  \n(\"relationship\"<|>HYPERTENSION<|>HEART FAILURE<|>Blood pressure reduction lowers heart failure risk by 49% in patients with coronary artery disease<|>7>)  \n##  \n(\"relationship\"<|>PERINDOPRIL<|>PROGRESS<|>Perindopril was the drug studied in the PROGRESS trial<|>9>)  \n##  \n(\"relationship\"<|>CCB<|>HYPERTENSION<|>CCB drugs are used to treat hypertension and reduce associated risks<|>8>)  \n##  \n(\"relationship\"<|>RAS INHIBITORS<|>HYPERTENSION<|>RAS inhibitors are a class of drugs used to treat hypertension<|>8>)  \n##  \n(\"relationship\"<|>Β RECEPTOR BLOCKERS<|>HYPERTENSION<|>Beta receptor blockers are used to treat hypertension and improve outcomes in coronary disease<|>8>)  \n##  \n(\"relationship\"<|>CORONARY ARTERY DISEASE<|>MYOCARDIAL INFARCTION<|>Coronary artery disease can lead to myocardial infarction<|>7>)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558742, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 650, "prompt_tokens": 2957, "total_tokens": 3607, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2880}, "prompt_cache_hit_tokens": 2880, "prompt_cache_miss_tokens": 77}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ��究是第一项证明 CCB降压治疗可以显著降低痴呆发生风险的随机对 照试验[551]  ,PROGRESS研究表明培哚普利可减轻高 血压患者的血管性认知障碍[552] 。荟萃分析评估了降 压药物类别对认知结局的影响 ,未报告任何一类降压 药优于其他类别[549,553-554] 。\n8.3   高血压合并冠心病\n\n要点 8C   高血压合并冠心病\n　　　·推荐血压<140/90mmHg作为合并冠心病  的高血压患者的降压目标( Ⅰ ,A) ,强化降压可能有  更多获益 ,如能耐受 ,可将血压降至<130/80mmHg ( Ⅱa,B) 。\n　　　·高血压合并稳定性冠心病患者 ,CCB、RAS抑 制剂、β 受 体 阻 滞 剂 均 有 充 分 的 证 据 可 以 应 用 ( Ⅰ ,A) 。\n　　　· 高血压合并心肌梗死患者,β受体阻滞剂和 RAS抑制剂在心肌梗死后长期服用可以明显改善远 期预后 ,没有禁忌证者应早期使用( Ⅰ ,A) 。\n\n　　　高血压是冠心病重要的独立危险因素 。在 52个 国家进行的国际心脏研究(INTERHEART) 显示 , 高 血压可以解释急性心肌梗死 25%~ 30%的人群归因 危险 度 , 仅 次 于 载 脂 蛋 白 B/载 脂 蛋 白  A1 比 值 (49.2%) 和吸烟(35.7%)[555] 。大型降压治疗临床试 验的荟萃分析显示 , 降压治疗可以显著降低冠心病风 险 , 收 缩 压 每 降 低  10 mmHg, 冠 心 病 风 险 降 低 17%[135] 。\n　8.3.1   降压目标    合并冠心病患者收缩压每降低 10mmHg,主要心血管事件风险降低 27% ,冠心病事 件风险降低 32% ,脑卒中风险降低 26% ,心力衰竭风 险降低 49% , 全因死亡风险 降 低 18%[135] 。 推 荐 血 压<140/90mmHg作为合并冠心病的高血压患者的 降压目标 ,强化降压可能有更多获益 ,如能耐受 ,可将血 压降至<130/80mmHg[141,556] 。高龄、存在冠状动脉严 重狭窄病变的患者 ,血压不宜过低 ,需要缓慢、逐步降 压 , 以防止重要脏器产生缺血不耐受情况[557] 。\n　8.3.2   降压治疗    (1) 稳定性冠心病 :高血压合并稳 定性冠心病患者 ,CCB、RAS抑制剂、β受体阻滞剂均 有充分的证据可以应用 ,其中 , CCB还可以降低心肌 氧耗量 ,减少心绞痛发作[244,557-558] 。使用上述药物血\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CCB<|>ORGANIZATION<|>CCB is a type of antihypertensive drug that has been shown to reduce the risk of dementia and lower myocardial oxygen consumption, reducing angina attacks in patients with stable coronary artery disease>  \n##  \n(\"entity\"<|>PROGRESS<|>ORGANIZATION<|>PROGRESS is a research study that demonstrated the effectiveness of perindopril in reducing vascular cognitive impairment in hypertensive patients>)  \n##  \n(\"entity\"<|>INTERHEART<|>ORGANIZATION<|>INTERHEART is an international heart study conducted in 52 countries, showing that hypertension accounts for 25%-30% of the population-attributable risk for acute myocardial infarction>)  \n##  \n(\"entity\"<|>RAS INHIBITORS<|>ORGANIZATION<|>RAS inhibitors are a class of antihypertensive drugs with evidence supporting their use in patients with hypertension and coronary artery disease>)  \n##  \n(\"entity\"<|>Β RECEPTOR BLOCKERS<|>ORGANIZATION<|>Beta receptor blockers are antihypertensive drugs that improve long-term prognosis in patients with myocardial infarction and are recommended for use in hypertension with coronary artery disease>)  \n##  \n(\"relationship\"<|>CCB<|>PROGRESS<|>Both CCB and PROGRESS study focus on antihypertensive treatments and their effects on cognitive and cardiovascular outcomes<|>4>)  \n##  \n(\"relationship\"<|>INTERHEART<|>CCB<|>INTERHEART study highlights hypertension as a major risk factor for coronary events, while CCB is a treatment option for such conditions<|>3>)  \n##  \n(\"relationship\"<|>RAS INHIBITORS<|>Β RECEPTOR BLOCKERS<|>Both RAS inhibitors and beta receptor blockers are recommended for hypertension patients with coronary artery disease or myocardial infarction<|>6>)  \n##  \n(\"relationship\"<|>PROGRESS<|>RAS INHIBITORS<|>PROGRESS study involves perindopril, an RAS inhibitor, demonstrating its benefits in hypertensive patients<|>5>)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_ad9b13022379106e07b9b7efd2019279186cfc3dd744f12980e63b5afa26e741_v2"}